EUVIMEDEUVIMED entdecken
Crossref

Analytical Method Development and Validation of Febuxostat using RP-HPLC

Rehan Riyaz Sayyad, Amit Kasabe, Ashok Bhosale

International Journal of Drug Delivery Technology · 03.07.2026 · 16 (61s)

DOI: 10.25258/ijddt.16.61s.166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 03.07.2026. Verfasst von Rehan Riyaz Sayyad und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Robust analytical method development and validation are indispensable pillars of pharmaceutical quality assurance, directly influencing the safety and efficacy of drug products released to patients. Febuxostat is a selective, non-purine xanthine oxidase inhibitor prescribed for the chronic management of hyperuricemia in gout patients. Reliable and well-characterized analytical methods are therefore essential for its quality control testing and regulatory submissions. The present study focuses on the development and validation of a simple, rapid, precise, and economical Reverse Phase High Performance Liquid Chromatographic (RP-HPLC) method for the quantitative estimation of Febuxostat. Preliminary characterization of the drug was carried out using UV spectroscopy, Fourier Transform Infrared Spectroscopy (FTIR), and Differential Scanning Calorimetry (DSC). Various chromatographic conditions were investigated to obtain optimum peak shape, resolution, and retention characteristics. The developed method was validated according to International Council for Harmonisation (ICH) guidelines for parameters including specificity, linearity, accuracy, precision, robustness, limit of detection, and limit of quantitation. The validated method demonstrated satisfactory analytical performance and can be successfully employed for routine quality control analysis of Febuxostat in bulk drug and pharmaceutical dosage forms.

Zitieren

APA

Sayyad, R. R., Kasabe, A., & Bhosale, A. (2026). Analytical Method Development and Validation of Febuxostat using RP-HPLC. International Journal of Drug Delivery Technology, 16(61s). https://doi.org/10.25258/ijddt.16.61s.166

Vancouver

Sayyad RR, Kasabe A, Bhosale A. Analytical Method Development and Validation of Febuxostat using RP-HPLC. International Journal of Drug Delivery Technology. 2026;16(61s). doi:10.25258/ijddt.16.61s.166

BibTeX
@article{Sayyad2026,
  author = {Sayyad, Rehan Riyaz and Kasabe, Amit and Bhosale, Ashok},
  title = {Analytical Method Development and Validation of Febuxostat using RP-HPLC},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {61s},
  doi = {10.25258/ijddt.16.61s.166}
}
Kostenlos starten →